Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page
- Check2 days agoChange DetectedRemoved the related topics entries for Type 2 diabetes and MedlinePlus Genetics from the page. This change affects discoverability but not the core study details.SummaryDifference0.2%

- Check9 days agoChange DetectedThe page revision label changed from v3.6.4 to v3.6.5, indicating a software update. No trial details or visible content were altered.SummaryDifference0.1%

- Check16 days agoChange DetectedThere are no additions or deletions to report. The page content appears unchanged with respect to the study details and related sections.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page revision line was updated from v3.6.3 to v3.6.4. This indicates a minor update to the page's version metadata rather than to the study details.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a minor version update to the study record page. This metadata change does not modify the study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2, reflecting a minor update to the page version without changing its content.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.